• 29. MARCH 2022
    A novel UHPLC-MS method targeting urinary metabolomic markers for autism spectrum disorder

    A novel UHPLC-MS method targeting urinary metabolomic markers for autism spectrum disorder

    AUTHORS: Olešová, D., Galba, J., Piešťanský, J., Celušáková, H., Repiská, G., Babinská, K., Ostatníková, D., Katina, S. and Kováč, A. ABSTRACT: Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed

    Viac
    • 1. MAY 2020
    A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

    A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

    AUTHORS: Olesova, D., Galba, J., Piestansky, J., Celusakova, H., Repiska, G., Babinska, K., Ostatnikova, D., Katina, S., Kovac, A.. ABSTRACT: Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed toViac